Despite the apparent paradox concerning the role of PAI-1 as an inhibitor of the urokinase proteolytic activity, the expression of the cognate gene (SERPINE1) strongly correlates with breast cancer metastasis and, in combination with uPA, represents a validated prognostic biomarker [84]. The gene discussed is PLAU; the disease is breast cancer.